Shoulder Replacement Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Anatomical Shoulder Prosthesis, Reverse Shoulder Prosthesis), By Procedure (Resurfacing Hemiarthroplasty, Reverse Total Shoulder Replacement, Stemmed Hemiarthroplasty, Total Shoulder Replacement), By End-User (Hospitals, Orthopedic Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.08 Billion
CAGR (2026-2031)	7.78%
Fastest Growing Segment	Resurfacing Hemiarthroplasty
Largest Market	North America
Market Size (2031)	USD 3.26 Billion

Market Overview

The Global Shoulder Replacement Market is projected to grow from USD 2.08 Billion in 2025 to USD 3.26 Billion by 2031 at a 7.78% CAGR. Shoulder replacement, defined as shoulder arthroplasty, involves the surgical removal of damaged bone and cartilage within the glenohumeral joint and their substitution with prosthetic components to restore mobility and alleviate pain. The primary drivers propelling the market include a rapidly aging global population and a rising incidence of osteoarthritis, which necessitates surgical intervention when conservative therapies prove ineffective. Furthermore, the increasing prevalence of sports-related injuries and trauma contributes to growing procedural volumes, providing a foundational demand that exists independently of transient market trends.

However, the sector encounters a significant challenge in the form of post-operative complications, such as implant loosening and infection, which can necessitate costly revision surgeries and deter patient adoption. These clinical risks are compounded by patient comorbidities that complicate surgical outcomes and recovery. According to the American Academy of Orthopaedic Surgeons, in 2025, the Shoulder & Elbow Registry Annual Report revealed that 51.2% of patients undergoing shoulder arthroplasty were categorized as obese, highlighting a critical demographic factor that surgeons must navigate to ensure long-term implant success.

Key Market Drivers

The technological integration of robotic-assisted surgical systems is fundamentally reshaping the Global Shoulder Replacement Market by enhancing implant placement accuracy and reducing revision rates. Surgeons are increasingly leveraging these advanced platforms to execute pre-operative planning with high precision, ensuring optimal glenoid component positioning which is critical for longevity. This shift towards tech-enabled surgery is not merely a clinical preference but a significant commercial catalyst, driving sales of compatible high-tech implant systems. According to Stryker Corporation, October 2025, in the 'Q3 2025 Earnings Call', the company reported robust double-digit organic sales growth in its Upper Extremities business, a performance directly bolstered by the sustained market demand for its advanced surgical solutions.

Simultaneously, the market is expanding due to the rising prevalence of rotator cuff tears and sports-related injuries, which are increasingly necessitating surgical intervention via reverse total shoulder arthroplasty. As active demographics age, the incidence of complex cuff tear arthropathy has surged, making replacement surgery a primary treatment pathway rather than a last resort. This trend is evident in large-scale registry data that tracks indication patterns over time. According to the American Academy of Orthopaedic Surgeons, October 2025, in the 'Shoulder & Elbow Registry 2025 Annual Report', rotator cuff tears were identified as the second largest primary diagnosis for patients undergoing shoulder arthroplasty among the 27,461 procedures analyzed. Furthermore, illustrating the broader procedural stability in developed regions, the National Joint Registry, September 2025, in its '22nd Annual Report', recorded exactly 9,809 shoulder replacement procedures performed during the most recent reporting period.

Download Free Sample Report

Key Market Challenges

Post-operative complications, particularly implant loosening and periprosthetic infections, represent a formidable barrier to the expansion of the global shoulder replacement market. These clinical failures not only compromise patient outcomes but also necessitate revision arthroplasty, which is technically demanding and significantly more expensive than primary surgery. The financial and physical burden of these adverse events creates a psychological deterrent for potential candidates, causing them to delay or decline surgical intervention despite debilitating joint pain. Consequently, the market faces friction as the risks associated with device failure dampen the adoption rates of otherwise effective prosthetic solutions.

The scale of this issue is amplified by the sheer volume of procedures performed, where even a marginal complication rate translates into a substantial absolute number of revisions that strain healthcare resources. According to the National Joint Registry, in 2025, the 22nd Annual Report indicated that 9,809 shoulder procedures were submitted for analysis during the preceding calendar year. As procedural volumes of this magnitude continue to rise, the cumulative burden of managing long-term implant survivorship acts as a critical restraint. This economic pressure directly impedes market trajectory by diverting funds and surgical capacity away from primary growth opportunities.

Key Market Trends

The rapid adoption of outpatient and ambulatory surgery center (ASC) procedures is fundamentally altering the site-of-care landscape for shoulder arthroplasty, driven by advancements in pain management and payer incentives. This migration is not merely a logistical shift but a strategic realignment, as healthcare providers increasingly prioritize cost-effective, high-efficiency settings for joint replacement. The operational and financial advantages of this model are evident in the performance of major facility operators who are aggressively expanding their orthopedic service lines. According to Surgery Partners, November 2025, in the 'Q3 2025 Earnings Call', the company reported that total joint surgeries in their ASC facilities grew 16% in the quarter, underscoring the accelerating volume shift toward non-hospital environments.

Simultaneously, the proliferation of 3D-printed patient-specific implants and instrumentation is redefining anatomical reconstruction by addressing the limitations of off-the-shelf prosthetics. Manufacturers are leveraging additive manufacturing to create highly porous titanium structures that mimic natural bone, thereby enhancing biologic fixation and long-term implant stability. This technological evolution is fueling significant commercial growth as surgeons demand more personalized solutions for complex glenoid deformities. According to Enovis Corporation, February 2025, in the 'Fourth Quarter and Full Year 2024 Results', the Reconstructive segment sales grew 59% on a reported basis, a surge directly attributed to the strategic acquisition and integration of LimaCorporate’s advanced 3D-printed implant portfolio.

Segmental Insights

Based on data from authoritative market research, the Resurfacing Hemiarthroplasty segment is recognized as the fastest-growing category in the Global Shoulder Replacement Market. This rapid expansion is primarily driven by a clinical paradigm shift toward bone-conserving techniques, which are increasingly critical for younger and physically active patients. Unlike traditional stemmed implants, resurfacing procedures preserve the native humeral bone stock, thereby significantly simplifying future revision surgeries. Furthermore, advancements in implant design and favorable clinical outcomes have bolstered surgeon confidence, leading to broader adoption across healthcare institutions prioritizing long-term joint preservation and patient mobility.

Regional Insights

North America leads the global shoulder replacement market due to the rising prevalence of osteoarthritis and a well-developed healthcare system. The region is supported by comprehensive reimbursement policies from the Centers for Medicare & Medicaid Services, which increase the accessibility of orthopaedic surgeries for the aging population. Furthermore, the presence of major medical device companies within the United States ensures consistent product availability and widespread clinical adoption. This combination of high demographic demand and favorable institutional frameworks secures North America’s position as the primary market globally.

Recent Developments

• In October 2025, Johnson & Johnson MedTech announced the United States launch of INHANCE INTACT, a proprietary instrumentation system developed for subscapularis-sparing total shoulder arthroplasty. This innovative system was designed to allow surgeons to perform shoulder replacements while keeping the subscapularis muscle intact, potentially reducing post-operative pain and accelerating recovery. The Worldwide President of Joint Reconstruction at Johnson & Johnson MedTech emphasized that this tissue-sparing approach supported the shift toward outpatient care by enabling patients to regain shoulder movement as early as the first day after surgery, marking a significant advancement in shoulder care.
• In December 2024, Zimmer Biomet Holdings, Inc. received FDA 510(k) clearance for the OsseoFit Stemless Shoulder System. This new implant was designed to match the natural anatomy of the patient's humerus, optimizing fit while preserving healthy bone during total shoulder replacement procedures. The system integrates with the company's existing humeral heads and glenoid options, allowing for a personalized surgical approach. The President of SET & CMFT at Zimmer Biomet highlighted that the system combined an anatomically shaped implant with proprietary porous metal technology to support biological fixation, addressing the needs of active patients requiring shoulder replacement.
• In February 2024, Smith+Nephew announced the full commercial availability of its AETOS Shoulder System in the United States. This launch coincided with the system receiving FDA clearance for use with the company's ATLASPLAN 3D Planning Software and patient-specific instrumentation. Designed for both anatomic and reverse total shoulder arthroplasty, the system features the Meta Stem, which is engineered for stability and bone preservation. A participating orthopedic surgeon noted that the system's flexibility and streamlined instrumentation offered significant benefits for both patients and surgical teams, particularly in ambulatory surgery center settings where efficiency is critical.
• In January 2024, Enovis Corporation completed the acquisition of LimaCorporate S.p.A, a global orthopedic leader known for its implant solutions. This strategic transaction strengthened Enovis' position in the global orthopedic reconstruction market by adding a complementary portfolio that includes 3D-printed Trabecular Titanium implants and a comprehensive revision offering for shoulders. The acquisition, valued at approximately €800 million, was intended to accelerate global growth and margin expansion. The Chairman and Chief Executive Officer of Enovis stated that this combination would create a fast-growing innovator in the sector, enhancing their ability to provide clinically differentiated solutions to patients and surgeons worldwide.

Key Market Players

• Arthrex Inc
• Zimmer Biomet Holdings Inc
• Integra LifeSciences Corporation
• Johnson & Johnson Services, Inc.
• Smith & Nephew PLC
• Wright Medical Group NV
• Stryker Corporation
• DJO Global Inc
• Acumed Inc
• Exactech Inc

By Type	By Procedure	By End-User	By Region
Anatomical Shoulder Prosthesis Reverse Shoulder Prosthesis	Resurfacing Hemiarthroplasty Reverse Total Shoulder Replacement Stemmed Hemiarthroplasty Total Shoulder Replacement	Hospitals Orthopedic Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Shoulder Replacement Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Shoulder Replacement Market, By Type:

• Anatomical Shoulder Prosthesis
• Reverse Shoulder Prosthesis

• Shoulder Replacement Market, By Procedure:

• Resurfacing Hemiarthroplasty
• Reverse Total Shoulder Replacement
• Stemmed Hemiarthroplasty
• Total Shoulder Replacement

• Shoulder Replacement Market, By End-User:

• Hospitals
• Orthopedic Centers
• Others

• Shoulder Replacement Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE